Contract 36C25022D0034
Binding Site, Inc., The · Department Of Veterans Affairs · February 25, 2022
Binding Site, Inc., The was awarded a federal contract by Department Of Veterans Affairs on February 25, 2022 for an undisclosed amount of work in biological product (except diagnostic) manufacturing. It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 18, 2026. If all options are exercised, the contract could reach $2.10 million.
Contract details
- PIID
- 36C25022D0034
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- First action
- February 25, 2022
- Latest action
- March 18, 2026
Description
OPTILITE REAGENT EXERCISING OY4 SF 30 ONLY. FUNDING WILL BE ON DO/TO
Modification timeline
-
March 18, 2026Mod P00005$0
-
February 17, 2026Mod P00004OPTILITE REAGENT EXERCISING OY4$0
-
September 24, 2024Mod P00003OPTILITE REAGENT EXERCISING OY2$0
-
March 1, 2023Mod P00002OPTILITE REAGENT EXERCISING OY1$0
-
March 3, 2022Mod P00001OPLILITE REAGENT RPOC LINE ITEMS COMPLIANCE 52.243-2$0
-
February 25, 2022Base awardOPLILITE REAGENT$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| American National Red Cross, The | Department Of Veterans Affairs | March 25, 2026 | $1.65M |
| New York Blood Center, Inc. | Department Of Veterans Affairs | March 18, 2026 | $670.0K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $137.6K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $102.8K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $124.6K |
| Mississippi Blood Services, Inc. | Department Of Veterans Affairs | March 11, 2026 | $451.2K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C25022D0034?
Contract 36C25022D0034 is a federal contract awarded to Binding Site, Inc., The by Department Of Veterans Affairs on February 25, 2022 for an undisclosed amount of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 5 times since the base award.
Who won contract 36C25022D0034?
Binding Site, Inc., The won contract 36C25022D0034 from Department Of Veterans Affairs.
How much is contract 36C25022D0034 worth?
Contract 36C25022D0034 has obligated $0 to date but carries a potential ceiling of $2.10 million if fully funded and all options are exercised.